iPhone Competition
advanced search

Welcome: Guest

log in

Martek Biosciences Corp: Premium Company Profile

Publication Date January 2008
Publisher Datamonitor
Product Type Databook
Pages 47
ISBN Number not applicable
Product Code DAT09536
Price

£265.00
approximately: $521 | €337

PDF Buy Now
PRINT £315 ($619 | €400) Buy Now
Order above formats by FAX Order by FAX

Summary

Introduction

Martek Biosciences (Martek) is a life-science based company that develops and commercializes naturally produced products derived from microalgae, fungi and other microbes. It's research is focused on identifying and creating commercially viable products for the nutraceutical, pharmaceutical and functional foods markets.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Martek's product focus is the development of nutritional products derived from microalgae, fungi and other microbes for the treatment of diseases in the area of inflammation, cognitive function and cardiovascular health. It has developed and patented two fermentable strains of microalgae which produce oils rich in docosahexaenoic acid (DHA).

A similar patented process was developed for a fungus that produces an oil rich in arachidonic acid, ARA. Both DHA and ARA are important nutrients for optimal infant development. It's product folio includes Neuromins brand DHA supplements containing life'sDHA is a vegetarian source of docosahexaenoic acid, DHA for pregnant women.

Martek derives majority of its revenues from the product sales of infant formula that contains nutritional oils as well as from the product sales of Neuromins, a DHA dietary supplement. It also generates revenues through contract manufacturing for the production of enzymes, specialty chemicals, vitamins and agricultural specialty products.

Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

  • Overview
  • Catalyst
    • Summary
    • Company Structure
    • Company Overview and Key Facts
    • Business Description
    • History
    • Locations and Subsidiaries
    • Company Financials
    • Stock Market Performance
    • P&L
    • Balance Sheet
    • Cash Flow
    • Business Segment Performance
    • Products & Services
    • Marketed Products
    • Competitors and Strategic Business Relationships
    • Top Competitors
    • Key Suppliers
    • Key Clients
    • Shareholding Structure
    • Strategy
    • Company View
    • Corporate Strategy
    • SWOT Analysis
  • Overview
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
    • Value Chain Analysis
  • Overview
    • Discovery and Product Development
    • Manufacturing
    • Sales
    • Key Employees
    • List of Key Employees
    • Key Employee Biographies
    • Financial and Operational Overview
    • Financial and Operational Overview
  • Appendix
    • Ask the analyst
    • Datamonitor consulting
    • Disclaimer
    • Figure 1: Martek Biosciences - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
    • Figure 2: Martek Biosciences - Key Strategic Revenues, 2002-2006 ($ Mn)
    • Table 1: Martek Biosciences - Key Facts
    • Table 2: Martek Biosciences - Other Locations and Subsidiaries
    • Table 3: Martek Biosciences - Year-End Share Price and Market Capitalization, 2002-2006 ($)
    • Table 4: Martek Biosciences - Key Events Impacting Share Price Performance
    • Table 5: Martek Biosciences - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
    • Table 6: Martek Biosciences - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
    • Table 7: Martek Biosciences - Balance Sheet, 2002-2006 ($ Mn)
    • Table 8: Martek Biosciences - Cash Flow, 2002-2006 ($ Mn)
    • Table 9: Martek Biosciences - Revenue Breakdown, 2002-2006 ($ Mn)
    • Table 10: Martek Biosciences - Marketed Products
    • Table 11: Martek Biosciences - Top Competitors
    • Table 12: Martek Biosciences - Key Clients
    • Table 13: Martek Biosciences - Key Shareholders
    • Table 14: Martek Biosciences - SWOT Analysis Summary
    • Table 15: Martek Biosciences - Value Chain Analysis
    • Table 16: Martek Biosciences - Key Employees
    • Table 17: Martek Biosciences - Financial and Operational Overview